Who will be protected from benefits reassessment under the government's welfare bill?
More than 200,000 people with severe, lifelong conditions will have their benefits protected and will not be reassessed, the government has announced as part of its new welfare bill.
"Robust protections will be put in place" so that those who are classified as severely disabled will be exempt from any future benefit assessments, and instead will be given the highest universal credit health top-up available, the government said.
These protections will come into effect when the government freezes and halves the universal health credit top-up in April 2026.
The rule is laid out in the government's welfare bill, which will see the government save at least £5bn by freezing and cutting the top-up as well as limiting who is eligible for disability benefit PIP.
Around 2.6 million people in the UK claim the universal credit health top-up, according to the latest figures, and 2.25 million of those people are set to be affected by the government's new rules.
While the exemption for those with the most severe conditions has been welcomed, there has been some confusion over who will be protected.
Yahoo News contacted the DWP but did not get a response at the time of publication.
Here's what we know about so far about who could be protected under the welfare bill.
The universal credit health-top up payment is provided in addition to a person's universal credit standard allowance.
It is designed to support those who have a health condition or disability that limits their ability to work, and for those over 18 and under state pension age.
Most people must undergo a work capability assessment to determine if they are eligible for it.
If you have a terminal illness and are expected to live for 12 months or less, you automatically qualify for the health top-up.
The government's own wording states more than 200,000 individuals who meet the severe conditions criteria (SCC) or are covered by the special rules for end of life (SREL) will be protected from future reassessment for universal credit entitlement.
"For those receiving the new reduced UC health element after April 2026, we are proposing that those with the most severe, life-long health conditions, who have no prospect of improvement and will never be able to work, will see their incomes protected through an additional premium," it said.
"We will also guarantee that for both new and existing claims, those in this group will not need to be reassessed in future."
The SREL rules identify and support anyone who is terminally ill, so it is highly likely that this group of claimants will be protected.
The SCC criteria is used to identify people with the most severe, lifelong, and permanently disabling health conditions or disabilities.
These people are classified as having severe, progressive, or irreversible physical or mental health conditions whose health is unlikely to improve.
It's worth bearing in mind that while 200,000 people will be protected, that covers just under 8% of people claiming the top-up.
We know that those who are classified as having limited capability for work will not be included in the 200,000.
Anyone whose condition has scope for improvement, such as some mental health conditions, will likely not be included.
We also know that from April 2022, anyone under the age of 22 will no longer be eligible for the universal credit health top-up.
The government said by removing the payment for this age group and reinvesting the money into work and training opportunities for younger people, it will incentivise people from this age group to get back into work.
The Joseph Rowntree Foundation has spoken out against this decision.
Iain Porter, the charity's senior policy adviser, said: "Slashing support for young disabled people is a cruel move that will push more families into hardship and poverty.'
While many disability and poverty campaigners have welcomed some protections, they have all been clear that they do not think they go far enough.
Disability equality Scope said while "it's right that people with the most severe conditions are protected, this is little comfort to the hundreds of thousands that will lose out."
"The vast majority of disabled people will not be covered by these protections and will face significant cuts to their support," James Taylor, the executive director of strategy at the charity said.
The Joseph Rowntree Foundation has warned that the changes to the welfare system will still push many families into hardship.
'Protecting 200,000 people is not enough when millions with significant health conditions will lose out. These changes will push more families into hardship and poverty," the charity said.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Fact-checking viral claims that WHO just listed the contraceptive pill as a carcinogen
Viral claims that the World Health Organisation (WHO) has 'just classified the pill as a group one carcinogen' are flooding TikTok, the Chinese-owned social media platform. 'The pill is now classified as a level-one carcinogen. Like tobacco. Like alcohol. Like drugs,' one TikToker claims, prompting alarm among users of the platform. Others urge their followers to stop taking the pill altogether. Euroverify has investigated these claims and found that, while the WHO's specialised cancer agency does consider some types of contraception pills to be carcinogenic to humans, the reality is much more nuanced. It's not true that the WHO has 'just' classified the pill as a carcinogen, as TikTok users have claimed. In fact, the International Agency for Research on Cancer (IARC) – the WHO's French-headquartered cancer agency – has included certain contraceptive pills on its list of substances 'carcinogenic to humans' since 2005. That list, known as Group 1, includes substances where 'sufficient evidence of carcinogenicity' has been demonstrated in 'studies in which chance, bias, and confounding were ruled out with reasonable confidence". There are two main types of the hormonal contraceptive pill: the combined pill, which contains the hormones oestrogen and progestogen, and the mini pill, which contains progestogen only. Only the combined pill is included on the WHO's so-called Group 1, meaning there's sufficient evidence that it can cause cancer in humans. The mini pill is currently categorised in the IARC's Group 2B, meaning it's considered "possibly carcinogenic to humans." Several studies, however, have found that both of these pills slightly increase the risk of breast cancer in women. For example, a 2023 study by Oxford University's Cancer Epidemiology Unit found that any type of hormonal contraceptive may increase the risk of breast cancer, and estimated that use of the mini pill is associated with 'a 20-30% higher risk of breast cancer". But there is also data to suggest the contraceptive pill can reduce the risk of other types of cancer, such as endometrial, colorectal and bowel cancers. It means the relationship between cancer and the contraceptive pill is much more complex than meets the eye. We detected several TikTok videos published in recent weeks claiming that the WHO considers the contraceptive pill "as carcinogenic" to humans as alcohol, tobacco and asbestos. This claim is misleading. The IARC's Group 1 includes all the substances for which there is sufficient evidence of carcinogenicity in humans, such as alcohol, tobacco and asbestos, as well as processed meats, sunlight radiation and certain viruses like Hepatitis B and C. But this doesn't mean in any way that all substances on the list carry the same risk level. It simply means there is sufficient scientific evidence to support the claim that they are all carcinogenic to humans. The IARC does not classify substances according to level of carcinogenicity, but rather according to the strength of the scientific evidence to support its link to an increased risk of cancer.
Yahoo
an hour ago
- Yahoo
Neurent Medical Announces Expanded Access Following Cigna Policy Update for NEUROMARK®
Effective September 15, CPT 31242 is no longer considered experimental, clearing an important barrier for ENT physicians treating chronic rhinitis. GALWAY, Ireland, June 30, 2025 /PRNewswire/ -- Neurent Medical, a leader in non-surgical treatments for chronic rhinitis, today announced that Cigna Healthcare will provide coverage for NEUROMARK treatment of the posterior nasal nerve by removing CPT 31242 posterior nasal nerve ablation using radiofrequency from its Experimental & Investigational (E&I) list, effective September 15th, 2025. This policy update is an important step in improving patient access to innovative treatment options for chronic rhinitis and reflects growing payer recognition of the procedure's therapeutic value. This update removes a key barrier that previously limited the ability for ENT physicians to treat Cigna patients using posterior nasal nerve ablation. "This is a significant moment for ENT providers and patients alike," said Brian Shields, CEO of Neurent Medical. "Cigna's reclassification of CPT 31242 reinforces the evolving understanding of chronic rhinitis and the role of targeted, minimally invasive interventions like NEUROMARK in managing the condition. We are committed to continue building on our large evidence base and working closely with the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) to support adoption across the US healthcare system" The NEUROMARK System delivers impedance-controlled, low-power radiofrequency (RF) energy to disrupt the parasympathetic nerve signals, addressing key symptoms of Chronic Rhinitis such as persistent nasal congestion and rhinorrhea (runny nose). "Chronic rhinitis can significantly affect an individual's wellbeing and patients need access to all available, medically sound solutions" said Dr. Peter Manes, Associate Professor at Yale School of Medicine. "This policy update is significant and helps otolaryngologists offer a modern, evidence-supported treatment with fewer administrative hurdles. The large and growing evidence base makes it more difficult for patients to be denied access to such technologies." Key Points for Providers: CPT 31242 is no longer classified as investigational by Cigna Precertification is not required under the updated policy (always confirm benefits per individual plan) The policy supports more streamlined access to NEUROMARK for eligible patients To view Cigna's updated medical policy, visit:CIGNA Policy LINK For more information about NEUROMARK, visit or contact your local Neurent Medical Sales Representative. About Neurent Medical Neurent Medical is pioneering innovative treatments for chronic inflammatory sinonasal diseases by targeting and safely disrupting hyperactive autonomic nerves that drive underlying inflammation. Its proprietary NEUROMARK® technology, with a unique design and advanced smart algorithmic control, allows physicians to precisely target and safely disrupt multiple underlying nerve branches in a single procedure to alleviate chronic rhinitis symptoms and improve patient quality of life. The venture capital-backed company is headquartered in Galway, Ireland, with US HQ in Braintree, MA. For more information visit PAM225r01 View original content to download multimedia: SOURCE Neurent Medical
Yahoo
2 hours ago
- Yahoo
Talks break down in last-ditch effort to keep Derby GP surgery open
Talks to keep a Derby GP surgery open and avoid closure have broken down, councillors have said. Park Medical Practice has proposed closing its Oakwood surgery on Bishops Drive permanently due to it being 'no longer fit for purpose' and concerns over public safety. Earlier this month the practice sent a text to patients detailing its plans for closure later this year and said services from the branch would move to its other surgeries in Chaddesden and Borrowash – the latter of which could be expanded subject to planning permissions. This has led to fears in the Oakwood community that people with mobility issues or those who are unable to drive may struggle to see their doctor near where they live. There is another GP surgery in the area but it is understood to be struggling with its capacity already. READ MORE: Two men assaulted in village near Derby after 'teenagers' jump out of car and launch attack READ MORE: Police update after murder investigation opened into death of Derbyshire man Join us on WhatsApp to get the latest news straight to your phone Park Medical Practice says the Bishops Drive building is now more than 40 years old and 'does not comply with the requirements of primary care standards in today's world'. Another issue is the building is not owned by the surgery. A final decision on its future is expected soon. The community concern has led councillors in the area to hold a meeting with the surgery and other stakeholders to see if there is a way in which closure can be avoided. But it appears the meeting proved unsuccessful. The councillors released the following statement: 'Unfortunately, a way forwards to keep the practice open was not found during this meeting, and we do not believe a way forwards to keep the practice open is likely to be found. 'Given the expansion happening at Borrowash, the reduced use of Oakwood over recent years, and issues with the condition of the building and ability to expand, we now expect that Park Medical Practice will continue to seek to close their Oakwood branch. 'We will also be working together to seek to improve transport networks between Oakwood and the Maine Drive and Borrowash PMP locations. This is not the update we wanted to issue, we really hoped that getting everyone together would allow us to find a solution... but it became clear that there was no way for Park Medical Practice to seek to remain.' Read more - Derby County face £5m transfer wait amid Patrick Agyemang development The Local Democracy Reporting Service has approached the practice for comment on the councillors' latest statement. Documents provided by the practice state there are several issues with the Oakwood branch surgery. These include: Very narrow corridors, steep steps outside to and from the car park, 'unsociable behaviour, including abuse to staff and patients' and the smashing of CCTV cameras. The report says: 'Upgrading the building to meet current standards and making it suitable for use would incur significant costs, which would not be justified by staff resources, overhead costs, and general running expenses. The site is unable to offer the complete range of services expected by CQC and NHS, and there is no scope for expansion. The building is not suitable for providing modern healthcare services. ' We send out the biggest stories in an email every day. Sign up for the main Derbyshire Live newsletter here.